Table 2.
Comorbidities at admission [data are expressed as n (%)].
| Comorbidities | In-hospital mortality |
p value a | OR (95% CI) | ||
|---|---|---|---|---|---|
| Yes | No | ||||
| No. of patients | 331 | 38 | 293 | ||
| Hypertensive disease | 211 (63.8) | 24 (63.2) | 187 (63.8) | 1.0 | |
| Atrial fibrillation | 53 (16.0) | 8 (21.1) | 45 (15.4) | 0.35 | 3.3 (1.6–6.8) |
| Congestive heart failure | 63 (19.0) | 15 (39.5) | 48 (16.4) | 0.002 | |
| Ischemic heart disease | 55 (16.6) | 9 (23.7) | 46 (15.7) | 0.24 | |
| Cerebrovascular disease | 50 (15.1) | 8 (21.1) | 42 (14.3) | 0.33 | |
| Dementia | 97 (29.3) | 11 (29.0) | 86 (29.4) | 1.0 | |
| Epilepsy | 5 (1.5) | 1 (2.6) | 4 (1.4) | 0.45 | |
| Parkinson disease | 23 (7.0) | 3 (7.9) | 20 (6.8) | 0.73 | |
| Chronic obstructive pulmonary disease | 38 (11.5) | 7 (18.4) | 31 (10.6) | 0.17 | |
| Asthma | 11 (3.3) | 5 (13.2) | 6 (2.1) | 0.004 | 7.2 (2.0–25.0) |
| Diabetes | 83 (25.1) | 9 (23.7) | 74 (25.3) | 1.0 | |
| Rheumatologic disease | 15 (4.5) | 11 (29.0) | 4 (1.4) | <0.001 | 29.4 (8.7–98.7) |
| Renal disease | 21 (6.3) | 0 | 21 (7.2) | 0.14 | |
| Lung cancer | 10 (3.0) | 6 (15.8) | 4 (1.4) | <0.001 | 13.5 (3.6–50.5) |
| Peripheral vascular disease | 2 (0.6) | 0 | 2 (0.7) | ||
| Ulcer disease | 4 (1.2) | 1 (2.6) | 3 (1.0) | ||
| Liver disease | 1 (0.3) | 0 | 1 (0.3) | ||
| Leukemia | 0 | 0 | 0 | ||
| Lynfoma | 1 (0.3) | 0 | 1 (0.3) | ||
| Metastatic solid tumor | 0 | 0 | 0 | ||
| AIDS | 0 | 0 | 0 | ||
| Number of comorbidities* | 3.5 (1–7) | 4.5 (3–7) | 3.1 (1–7) | <0.001b | |
| Number of comorbidities> 2 | 208 (62.8) | 32 (84.2) | 176 (60.1) | 0.002 | 3.5 (1.4–8.7) |
| CCI* | 2.4 (1–7) | 3.9 (3–7) | 2.5 (1–7) | <0.001 | |
| CCI > 2 | 129 (39.0) | 26 (68.4) | 103 (35.2) | <0.001 | 3.9 (1.9–8.2) |
| Age-adjusted CCI* | 5.3 (2–10) | 6.4 (4–10) | 5.2 (2–10) | <0.001b | |
| Age-adjusted CCI > 6 | 132 (39.9) | 29 (76.3) | 103 (35.2) | <0.001 | 5.9 (2.7–3.0) |
*Means and ranges.
CCI: Charlson Comorbidity Index.
a
Chi square test.
b
Student's t-test.